SCHEMBL6288506

SCHEMBL6288506

CCCCCc1ccc(CCC(=O)OCC)cc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP4F2 P78329 1/20 0.70
CYP4A11 Q02928 1/20 0.70
CYP4Z1 Q86W10 3/20 0.55
ALDH1A1 P00352 2/20 0.54
PPARG P37231 1/20 0.52
PPARA Q07869 1/20 0.52
CYP4F11 Q9HBI6 1/20 0.52
CYP4F12 Q9HCS2 1/20 0.52
FAAH O00519 1/20 0.51
ESR1 P03372 2/20 0.50
ADRA2A P08913 2/20 0.50
ADORA3 P0DMS8 2/20 0.50
TACR2 P21452 2/20 0.50
SLC6A2 P23975 2/20 0.50
SLC6A4 P31645 2/20 0.50
SLC6A3 Q01959 2/20 0.50
THRB P10828 2/20 0.50
ALOX5 P09917 1/20 0.50
KDM4E B2RXH2 1/20 0.50
LMNA P02545 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6286441 0.95 CYP4F2 (0.72) CYP4F2CYP4A11CYP4Z1ALDH1A1CYP4F11
SCHEMBL10929511 0.92 CYP4Z1 (0.60) CYP4F2CYP4A11CYP4Z1ALDH1A1PPARG
SCHEMBL11437256 0.91 CYP4F2 (0.77) CYP4F2CYP4A11CYP4Z1CYP4F11CYP4F12
SCHEMBL12780429 0.91 CYP4F2 (0.59) CYP4F2CYP4A11CYP4Z1ALDH1A1PPARG
SCHEMBL68902 0.89 CYP4F2 (0.85) CYP4F2CYP4A11CYP4Z1CYP4F11CYP4F12
SCHEMBL8754706 0.89 RARB (0.58) CYP4F2CYP4A11CYP4Z1ALDH1A1PPARG
SCHEMBL10206072 0.87 CYP4F2 (0.77) CYP4F2CYP4A11CYP4Z1CYP4F11CYP4F12
SCHEMBL9671800 0.86 CYP4Z1 (0.65) CYP4F2CYP4A11CYP4Z1ALDH1A1PPARG
SCHEMBL11134097 0.85 CYP4F2 (0.64) CYP4F2CYP4A11CYP4Z1PPARGPPARA
SCHEMBL10289901 0.85 CYP4Z1 (0.60) CYP4F2CYP4A11CYP4Z1ALDH1A1PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024098361-A1 ARTIFICIAL NUCLEIC ACID MOLECULE 斯微(上海)生物科技股份有限公司 2024-05-16 WO disclosed
US-6911468-B2 Tyrosine phosphatase inhibitors TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2005-06-28 US disclosed
US-20030144338-A1 Tyrosine phosphatase inhibitors TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2003-07-31 US disclosed
EP-1284260-A1 TYROSINE PHOSPHATASE INHIBITORS Takeda Chemical Industries, Ltd. (JP) 2003-02-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030144338-A1 Tyrosine phosphatase inhibitors PTPRC, PTPN1, PTPRM CYP4F2 1593/4885CYP4A11 1052/4885CYP4Z1 1490/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.